Operating
Increase (Decrease) In Right Of Use Asset, Operating Leases
Moderna Increase (Decrease) In Right Of Use Asset, Operating Leases decreased by 10.0% to -$11.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 22.2%, from -$9.00M to -$11.00M.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2019
Last reportedQ1 2026May 1, 2026
How to read this metric
Changes reflect the company's footprint expansion or contraction and the resulting accounting treatment of lease obligations.
Detailed definition
This metric reflects the non-cash adjustments related to the right-of-use assets created under operating lease accountin...
Peer comparison
Standard for all companies reporting under ASC 842 or IFRS 16 lease accounting standards.
Metric ID:
operating_increase_decrease_in_right_of_use_asset_operat_83f7e4Historical Data
17 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $16.00M | $11.00M | -$10.00M | -$10.00M | -$9.00M | -$4.00M | $13.00M | $648.00M | $0.00 | -$16.00M | $78.00M | $1.00M | -$9.00M | -$10.00M | -$9.00M | -$10.00M | -$11.00M |
| QoQ Change | — | -31.3% | -190.9% | +0.0% | +10.0% | +55.6% | +425.0% | >999% | -100.0% | — | +587.5% | -98.7% | <-999% | -11.1% | +10.0% | -11.1% | -10.0% |
| YoY Change | — | — | — | -162.5% | -181.8% | +60.0% | +230.0% | >999% | — | -300.0% | +500.0% | -99.8% | +43.8% | -112.8% | <-999% | — | -22.2% |
Range-$16.00M – $648.00M
CAGR-8.9%
Avg YoY Growth+521.2%
Median YoY Growth-61.0%
Current Streak2 quarters decline
Increase (Decrease) In Right Of Use Asset, Operating Leases at Other Companies
Frequently Asked Questions
- What is Moderna's increase (decrease) in right of use asset, operating leases?
- Moderna (MRNA) reported increase (decrease) in right of use asset, operating leases of -$11.00M in Q1 2026.
- How has Moderna's increase (decrease) in right of use asset, operating leases changed year-over-year?
- Moderna's increase (decrease) in right of use asset, operating leases decreased by 22.2% year-over-year, from -$9.00M to -$11.00M.
- What does increase (decrease) in right of use asset, operating leases mean?
- The non-cash adjustment for the usage of leased assets like office or lab space.